Imedex E-learning (audio)
Jennifer R. Brown, MD, PhD: Update on PI3K inhibitors: Idelalisib, copanlisib, duvelisib, umbralisib: Is toxicity the key?
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:18:36
- Mais informações
Informações:
Sinopse
Webcast: Navigating the Evolving Therapeutic Landscape of CLL: Strategies for the Optimal Application of Emerging Agents and Combinations in Practice
